美國的電生理學 (EP) 設備、切除設備市場 2016年 (至2022年的預測)
US Market for Electrophysiology and Ablation Devices - 2016 (Forecasted to 2022)
|出版商||iData Research Inc.||商品編碼||256190|
|出版日期||內容資訊||英文 120 Pages
|美國的電生理學 (EP) 設備、切除設備市場 2016年 (至2022年的預測) US Market for Electrophysiology and Ablation Devices - 2016 (Forecasted to 2022)|
|出版日期: 2015年09月01日||內容資訊: 英文 120 Pages||
電生理學 (EP)設備 、切除設備市場，包含導管消融術、診斷用EP導管、心臟內超音波 (ICE) 導管、冷凍導管消融術，及各種EP實驗室系統。電生理學 (EP) 設備 、切除設備市場預計在預測期間，由於人口的高齡化，心導管電氣燒灼術治療數的增加，及先進EP設備的引進而促進。
本報告提供美國的電生理學 (EP) 設備、切除設備市場相關調查、各市場區隔趨勢分析、市場規模的實際成果與預測、市場推動成長因素與抑制因素、各市場/市場區隔的詳細競爭分析等相關資料彙整。
The electrophysiology (EP) and ablation device market includes ablation catheters, diagnostic EP catheters, intracardiac ultrasound (ICE) catheters, cryoablation catheters and various EP lab systems.
Over the forecast period, the electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced EP devices. For the relatively newer devices used in electrophysiology and ablation markets, continued education is critical to increase cardiologists' confidence in these types of cardiac treatments. The EP market is expected to experience growth across all product segments over the forecast period. The more recent products are expected to experience strong growth on a percentage basis but not on an absolute unit or market growth basis simply because newer devices take a while for physicians to adopt. Also, considering the severity of the procedures, it will take years of practice before a device can fully take off. Therefore, most of the devices sold for newer market segments will go towards training and clinical studies.
Throughout the forecast period, there is expected to be a significant growth in demand for catheter-based ablation procedures due to an increase in public knowledge, technological improvements and an increase in the number of EP labs in rural areas.
Biosense Webster was the leading competitor in the EP lab system, ablation catheter and diagnostic EP catheter markets. The company has been able to maintain its dominant position in the market by offering a wide range of EP and ablation devices while utilizing their expansive distribution network to improve sales. The company retains its title as majority market leader in ablation. Other major competitors in the market include Angiodynamics, Biotronik, Boston Scientific, GE Healthcare, MicroPort, Siemens, Stereotaxis, St. Jude Medical and Topera. Certain companies, such as Boston Scientific and St. Jude Medical, also offer a wide range of EP and ablation products and sell them through large distribution networks.
This report covers market segments in:
This 356 Page Report Includes: